1st-line therapy of patients with Waldenström Macroglobulinemia: Treatment reality and outcome data from the German prospective TLN Registry. 2. Oktober 2018 Knauf, W., Slawik, H.R., Bückner, U., Houet, L., Wetzel, N., Jänicke, M., Marschner, N., 2018. Oncol Res Treat 41 (suppl 4)(P181), 47-48 Download MYRIAM: Prospective, intersectoral Real World cohort study for treatment and outcome of myeloma patients in Germany. Knauf, W., Engelhardt, M., Lipke, J., Losem, C., Kasper, C., Dörfel, S., Houet, L., Vannier, C., Jänicke, M., Marschner, N., Dechow, T., Einsele, H., 2018. Weiterlesen Does progression influence the quality of life? – Data from patients with advanced breast cancer from the MaLife-Project. Marschner N., Söling, U., Scholz, H., Azeh, I., Chiabudini, M., Kruggel, L., Jänicke, M., 2018. Oncol Res Treat 41 (suppl.4) (V493)… Weiterlesen